UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What are minimal important changes for asthma measures in a clinical trial?

The European respiratory journal, 1999-07, Vol.14 (1), p.23-27

1999

Volltextzugriff (PDF)

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

The European respiratory journal, 1999-07, Vol.14 (1), p.12-18

1999

Volltextzugriff (PDF)

Correlation of airway obstruction and patient-reported endpoints in clinical studies

The European respiratory journal, 2001-02, Vol.17 (2), p.220-224

2001

Volltextzugriff (PDF)

Variability and lack of predictive ability of asthma end-points in clinical trials

The European respiratory journal, 2002-11, Vol.20 (5), p.1102-1109

2002

Volltextzugriff (PDF)

Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial

Respiratory medicine, 2009-07, Vol.103 (7), p.995-1003

2009

Volltextzugriff (PDF)

Efficacy Of Montelukast For Allergic Rhinitis Concomitant With Asthma: Post-Hoc Analysis Based On New ARIA Guidelines

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S51-S51

2008

Volltextzugriff (PDF)

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

The European respiratory journal, 2003-01, Vol.21 (1), p.123-128

2003

Volltextzugriff (PDF)

A Responder Analysis Of Montelukast Compared With Placebo For Protection Against Exercise-Induced Bronchoconstriction - Pooled Results From 3 Studies

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S221-S221

2008

Volltextzugriff (PDF)

Prevention of Exercise-induced Bronchoconstriction by a Single Dose of Montelukast or Salmeterol

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S245-S245

2007

Volltextzugriff (PDF)

Distribution of therapeutic response in asthma control

The European respiratory journal, 2003-09, Vol.22 (3), p.568-569

2003

Volltextzugriff (PDF)

55 EVALUATION OF THE NK1 RECEPTOR ANTAGONIST, SERLOPITANT, IN PATIENTS WITH OVERACTIVE BLADDER: SUBGROUP ANALYSIS BY AGE AND DISEASE SEVERITY

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.134-134

2009

Volltextzugriff (PDF)

Increase in urinary leukotriene LT[E.sub.4] levels in acute asthma: correlation with airflow limitation

Thorax, 2004-02, Vol.59 (2)

2004

Volltextzugriff (PDF)

Efficacy of montelukast for treating perennial allergic rhinitis

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S267-S267

2005

Volltextzugriff (PDF)

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week, randomized, double-blind study

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S148-S148

2005

Volltextzugriff (PDF)

Onset and duration of single-dose protection of montelukast against exercise-induced bronchospasm

Journal of allergy and clinical immunology, 2005-02, Vol.115 (2), p.S11-S11

2005

Volltextzugriff (PDF)

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

Respiratory medicine, 2001-05, Vol.95 (5), p.379-386

2001

Volltextzugriff (PDF)

Protective effect of montelukast on both lower and upper respiratory responses to acute cat allergen exposure

Journal of allergy and clinical immunology, 2004-02, Vol.113 (2), p.S94-S94

2004

Volltextzugriff (PDF)

Montelukast, a leukotriene receptor antagonist, significantly improves symptoms of seasonal allergic rhinitis: Analysis of 5 spring and 2 fall studies

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S147-S147

2003

Volltextzugriff (PDF)

Efficacy of morning dosing of montelukast in seasonal allergic rhinitis (SAR)

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S84-S84

2003

Volltextzugriff (PDF)

Montelukast for treating seasonal allergic rhinitis: Effect of pollen counts in 3 fall studies

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S144-S144

2003

Volltextzugriff (PDF)

Flexible dosing of montelukast for treatment of seasonal allergic rhinitis: Morning or evening

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S146-S146

2003

Volltextzugriff (PDF)

Die Wirkung von Montelukast auf Rhinitissymptome bei Patienten mit Asthma und saisonaler allergischer Rhinitis

Allergologie, 2005-09, Vol.28 (9), p.343-354

2005

Volltextzugriff (PDF)

1131 Combination of montelukast and loratadine in seasonal allergic rhinitis: An analysis of three spring studies

Journal of allergy and clinical immunology, 2000, Vol.105 (1), p.S387-S387

2000

Volltextzugriff (PDF)

69 Evaluation of the safety profile of montelukast (MK-0476) in pediatric patients aged 2 to 5 years

Journal of allergy and clinical immunology, 2000, Vol.105 (1), p.S24-S24

2000

Volltextzugriff (PDF)

Abnormal Lung Gallium-67 Uptake Preceding Pulmonary Physiologic Impairment in an Asymptomatic Patient with Pneumocystis carinii Pneumonia

Chest, 1990-05, Vol.97 (5), p.1261-1263

1990

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What are minimal important changes for asthma measures in a clinical trial?

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

Correlation of airway obstruction and patient-reported endpoints in clinical studies

Variability and lack of predictive ability of asthma end-points in clinical trials

Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial

Efficacy Of Montelukast For Allergic Rhinitis Concomitant With Asthma: Post-Hoc Analysis Based On New ARIA Guidelines

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

A Responder Analysis Of Montelukast Compared With Placebo For Protection Against Exercise-Induced Bronchoconstriction - Pooled Results From 3 Studies

Prevention of Exercise-induced Bronchoconstriction by a Single Dose of Montelukast or Salmeterol

Distribution of therapeutic response in asthma control

55 EVALUATION OF THE NK1 RECEPTOR ANTAGONIST, SERLOPITANT, IN PATIENTS WITH OVERACTIVE BLADDER: SUBGROUP ANALYSIS BY AGE AND DISEASE SEVERITY

Increase in urinary leukotriene LT[E.sub.4] levels in acute asthma: correlation with airflow limitation

Efficacy of montelukast for treating perennial allergic rhinitis

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week, randomized, double-blind study

Onset and duration of single-dose protection of montelukast against exercise-induced bronchospasm

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

Protective effect of montelukast on both lower and upper respiratory responses to acute cat allergen exposure

Montelukast, a leukotriene receptor antagonist, significantly improves symptoms of seasonal allergic rhinitis: Analysis of 5 spring and 2 fall studies

Efficacy of morning dosing of montelukast in seasonal allergic rhinitis (SAR)

Montelukast for treating seasonal allergic rhinitis: Effect of pollen counts in 3 fall studies

Flexible dosing of montelukast for treatment of seasonal allergic rhinitis: Morning or evening

Die Wirkung von Montelukast auf Rhinitissymptome bei Patienten mit Asthma und saisonaler allergischer Rhinitis

1131 Combination of montelukast and loratadine in seasonal allergic rhinitis: An analysis of three spring studies

69 Evaluation of the safety profile of montelukast (MK-0476) in pediatric patients aged 2 to 5 years

Abnormal Lung Gallium-67 Uptake Preceding Pulmonary Physiologic Impairment in an Asymptomatic Patient with Pneumocystis carinii Pneumonia

Suchergebnisse filtern